Featured Article

Zoetis Pricing Spineometer: 5 of 5 Vertebrae

By Tim J. Smith, PhD September 2, 2026

Zoetis, a global leader in the animal health industry, had a positive FY 2026. Revenue rose 2.3% to $9.5 Y billion, and operating profits rose 5.4% to $3.8 billion over last year. A review of Zoetis’s 2 February 2026 earnings call and annual 10-K filing provided insight regarding the importance of pricing on performance. FACTS FROM EARNINGS CALL AND ANNUAL REPORT Wetteny Joseph, CFO, said of pricing, “Our pricing has always been…

In This Issue

Regeneron Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD October 1, 2025

Regeneron, a biotechnology company, had a mixed FY 2024. Revenue rose 8.3% to $14.2 billion, while operating profit fell 3.6% to $4.0…

Baxter Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD October 1, 2025

Baxter, a global healthcare product company, had a mixed FY 2024. Revenue rose 2.7% to $10.6 billion, while operating income fell 98%…

Improve Price Discipline and Value Capture at Our Company

By Tim J. Smith, PhD September 3, 2025

Challenge Our pricing is challenged by discipline and predictability in capturing our fair share of the value we deliver to customers. Recommendation…

Benchmarks and Recommended Size for the Pricing Function

By Tim J. Smith, PhD September 3, 2025

How large should a company’s pricing team be? How should executives and consultants even benchmark the size of a pricing team across…

WIGLAF, STRAIGHT
TO YOUR INBOX